Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2a study to investigate the efficacy, safety, tolerability, PK, and PD of
ATI-450 versus placebo in patients with moderate to severe psoriatic arthritis.